| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP1404308A1 Treatment of disorders secondary to organic impairments |
| 04/07/2004 | EP1404305A1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient |
| 04/07/2004 | EP1404302A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 04/07/2004 | EP1404295A2 Sustained release drug delivery devices with coated drug cores |
| 04/07/2004 | EP1404293A1 Infection control system |
| 04/07/2004 | EP1404174A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/07/2004 | EP1307457B1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 04/07/2004 | EP1182204B1 Crystals of carbapenem derivatives and pharmaceutical preparations for injection |
| 04/07/2004 | EP1150991B1 Compositions for treating inflammatory response |
| 04/07/2004 | EP1087783B1 Use of gastrin fragments or synthetic analogs of gastrin for the manufacture of a medicament for the treatment of helicobacter pylori-associated disorders |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | EP0968214B1 Purification process |
| 04/07/2004 | EP0787148B1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 04/07/2004 | EP0549742B1 USE OF CANPs-INHIBITORS IN PHARMACEUTICAL PREPARATIONS |
| 04/07/2004 | CN1487951A Peptides having affinity for the GP 120 viral protein and use thereof |
| 04/07/2004 | CN1487949A Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 04/07/2004 | CN1487942A Hexahydropyrrolo [1,2-c] pyrimidines as antiviral, antifungal and/or antitumor agents |
| 04/07/2004 | CN1487939A Amido ether substituted imidazoquinolines |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487840A Molecular antigen array |
| 04/07/2004 | CN1487838A Molecular antigen array |
| 04/07/2004 | CN1487835A Composition of hypochlorous acid and its applications |
| 04/07/2004 | CN1486990A Humanized gene engineering antibody resisting hepatitis E virus |
| 04/07/2004 | CN1486743A Chinese medicine injection and its production process |
| 04/07/2004 | CN1486741A Prepn process of coarse extrative of SARS virus resisting active matter from pore fungus |
| 04/07/2004 | CN1486738A Medicine for treating upper respiratory tract infection type cold |
| 04/07/2004 | CN1486735A Liver strengthening and protecting bolus as compound Chinese medicine for treating asthenia syndrome of hepatitis B |
| 04/07/2004 | CN1486728A Antibiotic and antiphlogistic medicine for women's disease and its prepn |
| 04/07/2004 | CN1486727A Externally applied medicine for treating women's inflammation and its prepn process |
| 04/07/2004 | CN1486720A Lotion for treating beriberi and tinea pedis |
| 04/07/2004 | CN1486699A Application of the effective part of Chinese medicinal material lindley eupatorium herb in preparing antiviral medicine |
| 04/07/2004 | CN1486691A Bolengsu compound and its prepn, medicine composition and use |
| 04/07/2004 | CN1144875C OMP 26 antigen of haemophilus influenzae |
| 04/07/2004 | CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same |
| 04/07/2004 | CN1144785C Hydroxamic acid and its preparation, and pharmaceutical composition |
| 04/07/2004 | CN1144597C Method for preparing genetic antibiotic peptide medicine for animals from transgenic antibiotic peptide muscidian vermicule and its application |
| 04/07/2004 | CN1144594C External-use plaster for softening dry feces and dissipating mass |
| 04/07/2004 | CN1144590C Low side-effect compound gentamicin preparation |
| 04/06/2004 | US6716981 Process for the preparation of N-(amino-4, 6-dihalo-pyrimidine) formamides |
| 04/06/2004 | US6716978 For therapy and prohylaxis of inflammatory diseases including joint inflammation, crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (copd) including asthma, chronic bronchitis |
| 04/06/2004 | US6716878 Antimicrobial agents |
| 04/06/2004 | US6716872 Using the compounds for treating pain, anxiety and various other diseases or conditions. |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 04/06/2004 | US6716850 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716843 Inhibitor of dipeptidyl-peptidase iv |
| 04/06/2004 | US6716836 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/06/2004 | US6716825 Osteoporosis and other disorders of bone metabolisum, cancer, viral infections, and the like. |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | US6716623 Compositions and methods for identifying antigens which elicit an immune response |
| 04/06/2004 | US6716430 Moderating immunology response |
| 04/06/2004 | US6716417 Condensation of heated vapor to form aerosol particles |
| 04/06/2004 | US6716416 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of an antipsychotic such as olanzapine, trifluoperazine, haloperidol, loxapine, clozapine, quetiapine, promazine, etc. |
| 04/06/2004 | US6716415 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of a sedative-hypnotic, such as zaleplon, zolpidem or zopiclone. |
| 04/06/2004 | US6715377 Drive system |
| 04/06/2004 | CA2171294C Viscous surfactant emulsion compositions |
| 04/06/2004 | CA2129430C N, n'-substituted imidocarbonimidic diamides derived from hydroxylamines |
| 04/06/2004 | CA2104114C Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents |
| 04/06/2004 | CA2084222C Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| 04/06/2004 | CA2067381C Treatment of hiv infections and compounds useful therein |
| 04/03/2004 | CA2453071A1 Genes and proteins for the production of polyene polyketides |
| 04/01/2004 | WO2004027053A1 Chicken astrovirus type 2 |
| 04/01/2004 | WO2004026899A1 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof |
| 04/01/2004 | WO2004026889A1 Antibiotic derivatives of erythromycin |
| 04/01/2004 | WO2004026882A1 Process for the preparation of cephems |
| 04/01/2004 | WO2004026875A1 Non-nucleoside reverse transcriptase inhibitors |
| 04/01/2004 | WO2004026874A1 Novel crystals of triazaspiro[5.5]undecane derivative |
| 04/01/2004 | WO2004026873A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 04/01/2004 | WO2004026862A1 Water-soluble triazole compound |
| 04/01/2004 | WO2004026854A1 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases |
| 04/01/2004 | WO2004026848A1 Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents |
| 04/01/2004 | WO2004026843A1 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 04/01/2004 | WO2004026833A1 Cyclic amine compound, process for producing the same, and use |
| 04/01/2004 | WO2004026832A1 Urea compound and use thereof |
| 04/01/2004 | WO2004026828A1 Pyrrole derivatives as antimycobacterial compounds |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026336A1 Improvements in or relating to vaccines |
| 04/01/2004 | WO2004026334A1 Antimicrobial composition and method for use |
| 04/01/2004 | WO2004026326A2 Antigen uptake receptor for candida albicans on dendritic cells |
| 04/01/2004 | WO2004026318A1 HEPATITIS C VIRUS INHIBITOR COMPRISING α-GLYCOSYLCERAMIDE AS THE ACTIVE INGREDIENT |
| 04/01/2004 | WO2004026311A2 Use of specific inhibitors of tyrosine kinases for immunomodulation |
| 04/01/2004 | WO2004026303A2 Use of posaconazole for the treatment of fungal infections |
| 04/01/2004 | WO2004026260A2 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 04/01/2004 | WO2004014928A3 Novel difluorinated gem compounds, preparation methods thereof and applications of same |
| 04/01/2004 | WO2004009123A3 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 04/01/2004 | WO2004005473A3 Hcv fusion proteins with modified ns3 domains |
| 04/01/2004 | WO2003106498A3 Ox40 (=cd134) receptor agonistic and therapeutic use |
| 04/01/2004 | WO2003106425A3 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 04/01/2004 | WO2003105767A3 Antifungal parenteral products |
| 04/01/2004 | WO2003104440A3 2,2-bis(hydroxymethyl)cyclopropylidenemethyl - purines and -pyrimidines as antiviral agents |
| 04/01/2004 | WO2003099256A3 FREE-FLOWING, POWDERY COMPOSITION CONTAINING α-LIPONIC ACID (DERIVATIVES) |
| 04/01/2004 | WO2003097658A3 Compounds and methods for inhibiting selectin-mediated function |
| 04/01/2004 | WO2003097633A8 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 04/01/2004 | WO2003097597A3 Indole derivatives and the use thereof as cb2 receptor ligands |
| 04/01/2004 | WO2003092718A3 Treatment and inhibition of ocular infections and wounds by cap37 and cap37 peptides |
| 04/01/2004 | WO2003090667A3 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| 04/01/2004 | WO2003089934A3 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1 |